Visiongain publishes Clinical Trials Materials Storage and Distribution Market Report 2020-2030

22 June 2020
Pharma

Visiongain has launched a new report Clinical Trials Materials Storage and Distribution Market Report 2020-2030: Forecasts by Type (Cold Chain, Non-Cold Chain), Product (Pharmaceutical, Diagnostic), and Medical Specialty (Oncology, Cardiology, and Immunology). PLUS, Major Developments in the Market PLUS COVID-19 Impact Analysis.

The global Clinical Trials Materials Storage and Distribution market for pharma is estimated to have reach $xyz mn in 2020, dominated by the clinical trial manufacturing segment. The global Clinical Trials Materials Storage and Distribution market for pharma is expected to grow at a CAGR of xyz% in the first half of the forecast period.

To access the data contained in this document please email contactus@visiongain.com

Report Scope

• Revenue and growth forecasts from 2020 to 2030 for the global Clinical Trials Materials Storage and Distribution market. This report also discusses the Drivers and Restraints of the global Clinical Trials Materials Storage and Distribution market.

• Revenue and growth forecasts from 2020 to 2030 for the leading submarkets of the global Clinical Trials Materials Storage and Distribution market:
• Manufacturing – also with sub forecasting for packaging and for other production
• Logistics and distribution – also with sub forecasts for cold chain logistics and for other services
• Supply chain management

This report discusses the Drivers and Restraints of each submarket.

• Revenue and growth forecasts from 2020 to 2030 for the leading national markets:
• United States
• Japan
• EU5: Germany, France, United Kingdom, Italy, Spain
• Brazil
• Russia
• China
• India
• Rest of the World

Revenues forecast for the US, Japan, EU5, Brazil, Russia, China, India are further broken down by submarket.

• This report profiles the leading companies offering Clinical Trials Materials Storage and Distribution services to the pharmaceutical industry:
• Thermo Fisher Scientific
• Catalent, Inc.
• Almac Group
• Lonza
• Paraxel International Corporation
• Mayne Pharma
• Eurofins Scientific
• PCI Sevices
• Biocair
• Intertek Group plc

• This report provides qualitative analysis of the Clinical Trials Materials Storage and Distribution market. This report discusses the Strengths, Weaknesses, Opportunities and Threats of the Clinical Trials Materials Storage and Distribution market. Social, Technological, Economic and Political factors that influence this market are also discussed.

• This report discusses trends in the Clinical Trials Materials Storage and Distribution market, clinical trial manufacturing market, comparator sourcing, clinical trial packaging, clinical trial supply chain management.

• This report discusses the regulatory outlook of the Clinical Trials Materials Storage and Distribution industry, outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials

Key Questions Answered by this Report:
• How is the Clinical Trials Materials Storage and Distribution market for pharma evolving?
• What are the drivers and restraints for the growth of the Clinical Trials Materials Storage and Distribution market for pharma?
• How will each Clinical Trials Materials Storage and Distribution submarket for pharma grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each Clinical Trials Materials Storage and Distribution submarket for pharma develop to 2030?
• What is the value of the leading Clinical Trials Materials Storage and Distribution submarket for pharma s in important regions of the world?
• What will be the main driver for the overall market to 2030?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market by 2030?
• Who are the leading players and what are their prospects over the forecast period?

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever